Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$230.61
+0.1%
$235.49
$147.33
$251.71
$554.67B0.277.67 million shs6.97 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,006.83
-0.9%
$939.86
$623.78
$1,133.95
$956.57B0.483.54 million shs1.75 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.74
-0.8%
$27.01
$22.09
$28.75
$147.96B0.3537.21 million shs24.05 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$398.84
-0.6%
$314.78
$234.60
$404.15
$364.31B0.648.53 million shs5.34 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.08%+3.70%-3.97%-5.24%+57.53%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.80%+3.28%+9.10%-3.20%+40.58%
Pfizer Inc. stock logo
PFE
Pfizer
-0.83%-2.78%-5.12%-6.65%+16.95%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-0.46%+7.90%+26.90%+35.97%+29.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$230.61
+0.1%
$235.49
$147.33
$251.71
$554.67B0.277.67 million shs6.97 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,006.83
-0.9%
$939.86
$623.78
$1,133.95
$956.57B0.483.54 million shs1.75 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.74
-0.8%
$27.01
$22.09
$28.75
$147.96B0.3537.21 million shs24.05 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$398.84
-0.6%
$314.78
$234.60
$404.15
$364.31B0.648.53 million shs5.34 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.08%+3.70%-3.97%-5.24%+57.53%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.80%+3.28%+9.10%-3.20%+40.58%
Pfizer Inc. stock logo
PFE
Pfizer
-0.83%-2.78%-5.12%-6.65%+16.95%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-0.46%+7.90%+26.90%+35.97%+29.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.74
Moderate Buy$253.049.73% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,218.3321.01% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.8412.05% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.72
Moderate Buy$378.88-5.00% Downside

Current Analyst Ratings Breakdown

Latest LLY, JNJ, UNH, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$26.00
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeHoldOutperform
5/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeMarket PerformOutperform$265.00
5/7/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
UpgradeSell (D+)Hold (C-)
5/7/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price Target$880.00 ➝ $900.00
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingBuy$1,183.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeBuy (B-)Buy (B)
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,325.00
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,350.00 ➝ $1,400.00
5/1/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOverweight$1,344.00
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.89$14.13 per share16.32$33.73 per share6.84
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B14.55$24.92 per share40.41$33.13 per share30.39
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.34$4.36 per share5.90$15.86 per share1.62
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$447.57B0.81$21.14 per share18.87$114.40 per share3.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6526.6618.332.2621.83%32.60%13.29%7/15/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1535.7722.751.1134.98%105.77%23.76%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.659.00N/A11.83%19.44%8.41%N/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$12.06B$13.2430.1219.391.732.68%14.65%4.77%N/A

Latest LLY, JNJ, UNH, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
4/21/2026Q1 2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.76$7.23+$0.47$6.90$109.84 billion$111.65 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.25%+5.25%60.12%64 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.69%+15.18%24.58%11 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.68%-13.20%131.30%16 Years
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.842.22%+12.57%66.77%15 Years

Latest LLY, JNJ, UNH, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.69%5/15/20265/15/20266/10/2026
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
2/24/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.213.1%3/9/20263/9/20263/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.80
0.80

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million940.42 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
390,000908.14 million905.60 millionOptionable

Recent News About These Companies

Promising Healthcare Stocks To Research - May 13th
Medical Stocks To Keep An Eye On - May 13th
UnitedHealth: TrumpRx Is A Nothingburger
Dow Closes Above 50,000 for First Time in Months
Forget UnitedHealth: Two Stocks To Buy Now
UnitedHealth: Beaten Down, Not Broken
Promising Medical Stocks To Watch Now - May 12th
Top Healthcare Stocks To Keep An Eye On - May 12th
Stock Market News for May 13, 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$230.61 +0.19 (+0.08%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$231.82 +1.21 (+0.52%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,006.83 -8.92 (-0.88%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$998.15 -8.68 (-0.86%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Pfizer stock logo

Pfizer NYSE:PFE

$25.74 -0.22 (-0.85%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$25.78 +0.04 (+0.16%)
As of 06:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$398.84 -2.32 (-0.58%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$392.22 -6.62 (-1.66%)
As of 06:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.